BACKGROUND The coronavirus disease 2019 (COVID-19) pandemic presents a significant
challenge to the medical profession, increasing in the presence of microbial co-infection …

Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …

Methods: The PubMed database was searched with the keywords;((Mucormycosis) OR
(invasive fungal sinusitis)) AND (COVID-19) and the PRISMA chart was prepared for the …

Fungal infections remain hardly treatable because of unstandardized diagnostic tests,
limited antifungal armamentarium, and more specifically, potential toxic interactions between …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Abstract Purpose of Review Severe-acute respiratory coronavirus 2 (SARS-CoV-2) causing
corona virus disease 2019 (COVID-19) has been the single most important pathogen driving …

Background Mucormycosis, a rare fungal infection, has shown an increase in the number of
reported cases during the COVID-19 pandemic. Objectives To provide a comprehensive …

Abstract COVID-19-associated mold infection (CAMI) is defined as development of mold
infections in COVID-19 patients. Co-pathogenesis of viral and fungal infections include the …

Mucormycosis is a serious and potentially fatal fungal infection caused by a type of rare but
opportunistic fungal pathogen called mucormycetes. Recently, mucormycosis, also known …